Abstract

Summary

This paper explores how circadian rhythm disruptions manifest in Parkinson's disease, with implications for therapeutic lighting interventions targeting ipRGC-mediated pathways. Understanding the blue-spectrum sensitivity of ipRGCs and screen-driven phase shifting has practical relevance for designing lighting environments in care settings for Parkinson's patients.
Abstract

Key Findings

  • ipRGCs display high affinity for the blue end of the light spectrum, which is more prevalent in cooler (higher color temperature) light sources
  • Screen proliferation has provided evidence of powerful circadian phase-shifting effects driven by blue-enriched light
  • Circadian disruption is identified as a notable feature of Parkinson's disease with implications for disease management
Categories

Categories

Dementia & Elder Care: Examines circadian rhythm disruptions specific to Parkinson's disease and their neurological implications.
Sleep & Circadian Health: Discusses circadian rhythm peculiarities including light-driven phase shifting via ipRGCs and melatonin pathways.
The Science of Light: References ipRGC blue-spectrum sensitivity and its role in circadian phase shifting relevant to lighting design.
Authors

Author(s)

L Rotaru, M Cebuc, A Lupușor, O Grosu
Publication Date

Publication Year

2023
View more publications